Ledger.Open graph →

SEC Form D · filed April 19, 2017

Fortress Biotech, Inc

Offering

—

Sold

$3.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NEW YORK, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

J. J. Lobell · New York, NYDirector Dov K. Klein · New York, NYDirector Eric K. Rowinsky · New York, NYDirector George K. Avgerinos · New York, NYExec Michael S. Weiss · New York, NYDirector Jimmie A. Harvey, Jr · New York, NYDirector Lindsay A. Rosenwald · New York, NYExec · Director Malcolm A. Hoenlein · New York, NYDirector Bernard J. Zahren · Avon, CTDirector Ivan Q. Zinn · New York, NYDirector Steve Traxler · Chicago, ILDirector Jeffrey Dachis · New York, NYExec · Director Raymond S. Chan · New York, NYDirector Richard V. Kretz · Avon, CTDirector Spencer J. Raymond · Boston, MAExec Julianne J. Hull · BOSTON, MADirector Lucy S. Lu · Chicago, ILExec John S. Struck · Hamilton, BermudaExec · Director Ethan Kay · Irvine, CADirector Philippe S. Schaison · Newport Beach, CADirector Douglas Bateson · Wilton, CTDirector Christina Lampe-Onnerud · Wilton, CTDirector Per Onnerud · Wilton, CTDirector Declan Shalvey · Wilton, CTDirector Mark Van Der Zwan · WEST CONSHOHOCKEN, PAExec Lucy S. Lu · Chicago, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗